Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000950170-24-114386

Options or other derivatives

  • EVP Strategy and CBO acquired 8,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kronmiller Matthew EVP Strategy and CBO 2024-10-09 Grant or award · Stock Option (right to buy) +8,600 8,600 D: show line 1 in the form
Loading xslF345X05/ownership.xml…